Johnson & Johnson halts late-stage E.coli vaccine trial

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.
J&J, Sanofi stop E.coli vaccine trial due to low effectiveness
Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies said on Thursday.
Sanofi Ends E.coli Vaccine Trial Amid Efficacy Concerns
Sanofi ( ($SNY) ) has provided an announcement. On February 13, 2025, Sanofi announced the discontinuation of the E.mbrace phase 3 study for its
J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results
The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.
J&J to discontinue E.coli vaccine candidate study
Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi. The drugmaker said its decision was based on t
Sanofi and J&J discontinue late stage trial of their experimental E.coli vaccine
Sanofi (NASDAQ:SNY) said on Thursday that it is discontinuing the late-stage trial for its vaccine to prevent E. coli bacteria infection as it failed to demonstrate sufficient efficacy. The vaccine for extraintestinal pathogenic E.
Abandoned in the Middle of Clinical Trials, Because of a Trump Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...
How Do You Know If a Clinical Trial Is Right for You?
You're thinking of participating in a clinical trial – what now? Ask questions and weigh the risks before deciding if a clinical trial is right for you.
Clinical trial finds RNA inhibitor effectively reduces 'bad cholesterol' in patients with cardiovascular disease
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
Ozempic 'Significantly' Lowered 'Alcohol Craving' in First Clinical Trial, with Those Taking the Drug Drinking 40% Less
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Ozempic Trial Shows Drug Turns People Off Alcohol
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
HUB1d
NIH funds research that leads directly to cancer treatments, clinical trials
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...
The Lancet1d
Identifying key randomised clinical trials that could transform clinical care and public health
Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...
Sierra Sun Times13h
NIH-Funded Clinical Trial will Evaluate New Dengue Therapeutic
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
Clinical trial helps man with leukemia live decades longer
Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...
News Medical on MSN6d
New clinical trial aims to improve outcomes for older adults with hip fractures
Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic ...
Hosted on MSN8h
Lindus Health to partner with CDISC for trial data standardisation using AI
Biomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.